Actualités 2024/04/17 Addex Therapeutics lance la spin-off Neurosterix à Genève avec un investissement de USD 63 millions La société genevoise Addex Therapeutics s’est associée à Perceptive Advisors pour lancer la spin-off Neurosterix, un nouvel acteur dans le dévelo...
News 2024/04/17 Addex Therapeutics launches spin-off Neurosterix in Geneva with USD 63 million investment Geneva's Addex Therapeutics has teamed up with Perceptive Advisors to launch spin-off Neurosterix, a new player in neurology-focused drug develop...
Success stories 2024/04/04 Snake venum for the Spanish pharma industry Pentapharm, a science-based company located in the Basel area, is a leading international supplier of high-quality biochemical materials for vari...
News 2024/02/29 Top Stories from Western Switzerland (February 2024) From significant strides in semiconductor innovation and breakthroughs in medical research to strategic advancements in fintech and medtech secto...